HYPD
Hyperion DeFi, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$34.97M
P/E Ratio
—
EPS
$-9.40
Beta
2.63
52W High
$17.18
52W Low
$0.89
50-Day MA
$3.48
200-Day MA
$6.22
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 813,460 |
| Gross Profit (TTM) | 510,160 |
| EBITDA | $-17.45M |
| Operating Margin | -3609.00% |
| Return on Equity | -324.10% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.16 |
| Book Value | $4.73 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 42.99 |
| EV/Revenue | 36.19 |
| EV/EBITDA | -5.41 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1666.00% |
| Shares Outstanding | $11.39M |
| Float | $9.20M |
| % Insiders | 28.74% |
| % Institutions | 12.38% |
Analyst Ratings
Consensus ($6.28 target)
2
BuyData last updated: 4/8/2026